Cargando…
Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial
BACKGROUND: Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pathological lymph node excision, which must be marked by a reliable marker befor...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439625/ https://www.ncbi.nlm.nih.gov/pubmed/37596658 http://dx.doi.org/10.1186/s12957-023-03147-x |